Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Midazolam for Sedation in Diagnostic Upper Gastrointestinal Endoscopy
KCT0008128Phase 4Completed
- Sponsor
- Hana Pharm
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in None, sponsored by Hana Pharm. Started Feb 2023; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on KCT0008128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008128.